Greg Ikonen is listed as an executive officer on 1 SEC Form D filing by 1 issuer in Sep 2011: MENDEL BIOTECHNOLOGY INC (Hayward, CA — other technology — 2011; $11.8M reported sold to 10 investors).
What this means One deal on file with the SEC, filed Sep 2011. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Brian Staskawicz (1 shared filing), Justin Adams (1 shared filing), Mark N. Lampert (1 shared filing), Neal Gutterson (1 shared filing), Neil Wallack (1 shared filing) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Greg. Each name links to their own page.
The issuer belongs to the sponsor group Radicle (3 issuers, $96.8M reported sold, 2011–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Radicle has 3 companies on file and $96.8M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 1 public filing for Greg Ikonen and found 3 differences, 1 worth asking the sponsor about: Form D filed 1,563 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.